Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher ...

Pfizer Inc Chief Executive Officer Albert Bourla sold $5.56 million worth of company shares on Monday, the day the drugmaker said its COVID-19 vaccine was 90% effective based on interim trial results, ...

Work to distribute the experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE is gearing up after the companies announced successful interim data earlier on Monday , but it will not be ...

Pharmacies and GoodRx are in talks to join TrumpRx, a new drug pricing site aiming to lower prescription costs for U.S.

By stepping out as the first biopharma to win a three-year exemption from President Donald Trump’s earlier-announced plans for 100% tariffs, in return for agreeing to manufacture more of its drugs in ...

Pfizer's stock has been struggling for multiple years, and even a low valuation hasn't made it an enticing option for many ...

Proponents of Health and Human Services Secretary Robert F. Kennedy Jr.’s “Make America Healthy Again” (MAHA) agenda are outraged over the Trump administration’s deal with ...

Major stock indexes ended higher for a third straight session Tuesday, hours ahead of a deadline for congressional leaders to ...

President Donald Trump announced a deal with Pfizer to bring down drug costs, but experts warned it might not help Americans ...

President Donald Trump celebrated a long-promised victory Tuesday, announcing that he had used the threat of tariffs to prod pharmaceutical giant Pfizer into cutting U.S. drug prices. But the deal, ...

Pfizer and the rest of the biopharmaceutical industry have faced significant uncertainty. This uncertainty is due to the ...

The announcement made yesterday regarding Pfizer’s agreement with the White House to reduce drug prices in exchange for a ...